NCT06930274

Brief Summary

The goal of this observational study is to identify a novel biomarker for stillbirth. Specifically the aim is to predict perinatal hypoxia using quantitative ultrasound from the placenta (QUS-P) between 35 and 37 weeks gestation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
282

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2023

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 16, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

2.6 years

First QC Date

April 1, 2025

Last Update Submit

April 8, 2025

Conditions

Keywords

Quantitative UltrasoundPlacentaStillbirthFetal Hypoxia

Outcome Measures

Primary Outcomes (1)

  • Presence of Perinatal Hypoxia at 35-37 weeks gestation

    Perinatal hypoxia is defined as meeting one or more of the following: 1. Apgar \< 7 at 5 minutes 2. Umbilical artery pH \< 7.1 3. Neonatal cardiac resuscitation performed (includes CPAP, intubation and ventilation, or cardiopulmonary resuscitation) 4. Neonatal encephalopathy (Severe brain injury diagnosed within the first 7 days of life defined as: was therapeutically cooled; and/or had decreased central tone or was comatose and had seizures of any kind; and/or had amplitude integrated electroencephalography (aEEG abnormality) in the first 24 hours of birth. )

    35-37 weeks gestation

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Potential participants are recruited from the following sources: 1. South Community Birth Program 2. Maternal Fetal Medicine Clinics at BC Women's Hospital (EMMA and Fetal Monitoring)

You may qualify if:

  • Pregnant with singleton
  • Age 19 years or older
  • Provision of informed consent
  • Planning to deliver at BC Women's Hospital
  • weeks gestation or less

You may not qualify if:

  • Pregnant with multiples
  • Not planning to deliver at BC Women's Hospital
  • Less than 19 years of age
  • Greater than 38 weeks gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Community Birth Program

Vancouver, British Columbia, V5V 3C9, Canada

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

placenta

MeSH Terms

Conditions

StillbirthFetal Hypoxia

Condition Hierarchy (Ancestors)

Fetal DeathPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeathPathologic ProcessesPathological Conditions, Signs and SymptomsFetal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHypoxiaSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Robert Rohling, PhD

    The University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tiffany Reeve, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 1, 2025

First Posted

April 16, 2025

Study Start

January 3, 2023

Primary Completion

July 30, 2025

Study Completion

September 30, 2025

Last Updated

April 16, 2025

Record last verified: 2025-04

Locations